Stocktoria
Penumbra Inc PEN
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2015-09-18
Penumbra Inc statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% |
| Operating margin | 13.5% | 0.8% | 6.9% | 0.7% | -1.0% |
| Net margin | 12.7% | 1.2% | 8.6% | -0.2% | 0.7% |
| FCF margin | 12.5% | 12.3% | 7.8% | -8.8% | -1.6% |
| Return on assets | 9.7% | 0.9% | 5.8% | -0.1% | 0.4% |
| Return on equity | 12.4% | 1.2% | 7.7% | -0.2% | 0.6% |
| Current ratio | 6.64 | 6.01 | 6.06 | 5.21 | 5.53 |
| Revenue growth | 17.5% | 12.9% | 25.0% | 13.3% | 33.4% |
Source: SEC EDGAR filings · CIK 0001321732 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.